tiprankstipranks
Japan Hospice Holdings Inc. (JP:7061)
:7061
Japanese Market
Want to see JP:7061 full AI Analyst Report?

Japan Hospice Holdings Inc. (7061) AI Stock Analysis

0 Followers

Top Page

JP:7061

Japan Hospice Holdings Inc.

(7061)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
¥648.00
▼(-42.14% Downside)
Action:Reiterated
Date:05/19/26
The score is primarily weighed down by weakening profitability, high leverage, and consistently negative free cash flow, which increases financing and execution risk. Technicals add further pressure due to a clear downtrend and weak momentum. Valuation is somewhat supportive with a moderate P/E and solid dividend yield, but not enough to offset the fundamental and technical headwinds.
Positive Factors
Revenue Growth
Sustained top-line growth through 2025 indicates the company's core hospice services are expanding. Persistent revenue increases support scale benefits, potential operating leverage over time and provide a foundation for reinvestment in facilities and staff if managed alongside margin recovery.
Negative Factors
High Leverage
Elevated and rising leverage materially limits financial flexibility and increases refinancing and interest-rate vulnerability. High debt relative to equity reduces capacity to absorb shocks, constrains strategic investment, and raises the risk that weaker earnings translate into covenant or liquidity stress.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line growth through 2025 indicates the company's core hospice services are expanding. Persistent revenue increases support scale benefits, potential operating leverage over time and provide a foundation for reinvestment in facilities and staff if managed alongside margin recovery.
Read all positive factors

Japan Hospice Holdings Inc. (7061) vs. iShares MSCI Japan ETF (EWJ)

Japan Hospice Holdings Inc. Business Overview & Revenue Model

Company Description
Japan Hospice Holdings Inc. engages in hospice housing and home care businesses in Japan. The company offers care services at hospice housing for patients with terminal cancer and intractable diseases; and home-visit nursing services. It also prov...
How the Company Makes Money
null...

Japan Hospice Holdings Inc. Financial Statement Overview

Summary
Revenue has grown steadily, but 2025 profitability weakened sharply (gross/net margin compression and lower net income despite higher sales). The balance sheet remains highly leveraged (debt-to-equity ~3.6x) and returns have deteriorated. Cash quality is a key concern: operating cash flow is positive, yet cash conversion is weak and free cash flow has been negative in most years, including deeply negative in 2024–2025.
Income Statement
58
Neutral
Balance Sheet
45
Neutral
Cash Flow
34
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue13.13B14.17B12.12B9.87B7.89B6.02B
Gross Profit1.97B1.84B2.11B1.92B1.58B1.12B
EBITDA1.76B1.43B1.82B1.79B1.40B852.01M
Net Income529.62M278.01M639.58M681.88M454.73M240.80M
Balance Sheet
Total Assets17.98B18.92B18.31B15.16B11.45B9.15B
Cash, Cash Equivalents and Short-Term Investments1.40B2.01B1.53B1.88B1.51B1.04B
Total Debt12.70B13.18B13.19B10.89B8.09B6.67B
Total Liabilities14.47B15.25B14.86B12.47B9.41B7.61B
Stockholders Equity3.52B3.68B3.45B2.69B2.01B1.54B
Cash Flow
Free Cash Flow0.00-1.32B-2.27B-865.26M340.76M-1.45B
Operating Cash Flow0.001.05B835.74M1.13B873.83M467.10M
Investing Cash Flow0.00-511.73M-2.79B-1.01B48.27M-1.98B
Financing Cash Flow0.00-47.03M1.60B256.45M-448.16M1.59B

Japan Hospice Holdings Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1120.00
Price Trends
50DMA
762.72
Negative
100DMA
905.36
Negative
200DMA
1072.97
Negative
Market Momentum
MACD
-19.27
Positive
RSI
25.45
Positive
STOCH
10.31
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7061, the sentiment is Negative. The current price of 1120 is above the 20-day moving average (MA) of 739.40, above the 50-day MA of 762.72, and above the 200-day MA of 1072.97, indicating a bearish trend. The MACD of -19.27 indicates Positive momentum. The RSI at 25.45 is Positive, neither overbought nor oversold. The STOCH value of 10.31 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7061.

Japan Hospice Holdings Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥40.86B11.512.63%3.49%-14.24%
62
Neutral
¥35.39B12.320.91%9.10%-54.63%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥5.56B23.204.07%4.75%20.56%
51
Neutral
¥2.78B24.822.56%-6.54%-69.23%
46
Neutral
¥6.13B19.081.41%16.83%-45.33%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7061
Japan Hospice Holdings Inc.
661.00
-482.19
-42.18%
JP:2373
Care Twentyone Corporation
410.00
27.91
7.30%
JP:2425
Care Service Co., Ltd.
720.00
-44.05
-5.77%
JP:6062
Charm Care Corporation
1,219.00
49.43
4.23%
JP:7071
Amvis Holdings.Inc.
345.00
-71.24
-17.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 19, 2026